Bloomberg Law
Health Law & Business
LinkedIn

FDA Warns Against Using Certain Celltrion Covid Tests

March 1, 2022, 5:16 PM UTC
Erin McClam
Erin McClam
Bloomberg News

FDA warns against using certain Celltrion USA Inc. DiaTrust Covid-19 Ag Rapid Tests.

  • Tests not authorized, cleared, or approved by the FDA for distribution or use in U.S.; FDA says concerned about the risk of false results

To view the source of this information, click here

To contact the reporter on this story:
Erin McClam in Boston at emcclam@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© 2022 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.